P-15 cell-binding domain derived from collagen: Analysis of MG63 osteoblastic-cell response by means of a microarray technology

Journal of Periodontology

Volumn 75, Issue 1, 2004, Pages 66-83

  Carinci, Francesco ^a   Pezzetti, Furio ^b,c   Volinia, Stefano ^a   Laino, Gregorio ^d   Arcelli, Diego ^a   Caramelli, Elisabetta ^b,c   Degidi, Marco ^e,f   Piattelli, Adriano ^e,f  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c CARISBO Foundation   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e UNIVERSITY OF CHIETI   (Italy)

^f NONE   (Italy)

Author keywords

Cell culture; Cell cycle; Collagen; Gene expression regulation; Genes, P 15; Osteogenesis

Indexed keywords

BINDING PROTEIN; COLLAGEN; PROTEIN P15;

APOPTOSIS; ARTICLE; BONE DEVELOPMENT; CELL ANCHORAGE; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CELL MIGRATION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MOLECULAR GENETICS; OSTEOBLAST; SIGNAL TRANSDUCTION; UPREGULATION;

APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; COLLAGEN; COLLAGEN TYPE I; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOBLASTS; OSTEOGENESIS; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION;

EID: 1542330702     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.1.66     Document Type: Article

References (32)

1. Yukna RA, Callan DP, Krauser JT, et al. Multi-center clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects. 6-month results. J Periodontol 1998;69:655-663.
2. Bhatnagar RS, Qian JJ, Gough CA. The role in cell binding of a beta-bend within the triple helical region in collagen alpha1 (1) chain: Structural and biological evidence for conformational tautomerism on fiber surface. J Biomol Struct Dyn 1997;14:547-560.
3. Qian JJ, Bhatnagar RS. Enhanced cell attachment to anorganic bone mineral in the presence of a synthetic peptide related to collagen. J Biomed Mater Res 1996;31: 545-554.
4. Bhatnagar RS, Qian JJ, Wedrychowska A, Sadeghi M, Wu YM, Smith N. Design of biomimetic habitat for tissue engineering with P-15, a synthetic peptide analogue of collagen. Tissue Eng 1999;5:53-65.
5. Bhatnagar RS, Qian JJ, Wedrychowska A, Dixon E, Smith N. Biomimetic habitat for cells: Ordered matrix deposition and differentiation in gingival fibroblasts cultured on hydroxyapatite coated with a collagen analogue. Cell Mater 1999;9:93-104.
6. Lallier TE, Yukna R, St. Marie S, Moses R. The putative collagen binding peptide hastens periodontal ligament cell attachment to bone replacement graft materials. J Periodontol 2001;72:990-997.
7. Krauser JT, Rohrer MD, Wallace SS. Human histologic and histomorphometric analysis comparing Osteograf/N with PepGen P-15 in the maxillary sinus elevation procedure: A case report. Implant Dent 2000;9:298-302.
8. Yukna RA, Salinas TJ, Carr RF. Periodontal regeneration following use of ABM/p-15: A case report. Int J Periodontics Restorative Dent 2002;22:146-155.
9. Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M. Thirty-six month follow-up of 25 patients treated with combination anorganic bovine-derived hydroxyapatite matrix (ABM) cell-binding peptide (P-15) bone replacement grafts in human infrabony defects. I. Clinical findings. J Periodontol 2002;73:123-128.
10. Schilepake H. Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 2002;31: 469-484.
11. Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M. Multi-center clinical comparison of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) and ABM in human periodontal osseous defects. 6-month results. J Periodontol 2000;71:1671-1679.
12. Barbosa EP, de Souza RO, Caula AL, Neto LG, Caula FDE O, Duarte ME. Bone regeneration of localized chronic alveolar defects utilizing cell binding peptide associated with anorganic bovine-derived bone mineral: A clinical and histological study. J Periodontol 2002;73:1153-1159.
13. Carinci F, Francioso F, Rubini C, et al. Genetic portrait of malignant granular cell odontogenic tumour. Oral Oncol 2003;39:69-77.
14. Carinci F, Volinia S, Pezzetti F, Francioso F, Tosi L, Piattelli A. Titanium-cell interaction: Analysis of gene-expression profiling. J Biomed Mater Res 2003;66:341-346.
15. Carinci F, Francioso F, Volinia S, et al. Expression profiling of ameloblastic carcinoma. J Craniofac Surg. In press.
16. Carinci F, Bodo M, Tosi L, et al. Expression profiles of craniosynostosis-derived fibroblasts. Mol Med 2002;8: 638-644.
17. Francioso F, Carinci F, Tosi L, et al. Identification of differentially expressed genes in human salivary gland tumors by DNA microarrays. Molec Cancer Ther 2002;1:533-538.
18. Ibraghimov-Beskrovnaya O, Milatovich A, Ozcelik T, et al. Human dystroglycan: Skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum Mol Genet 1993;2:1651-1657.
19. Dzamba BJ, Wu H, Jaenisch R, Peters DM. Fibronectin binding site in the type I collagen regulates fibronectin fibril formation. J Cell Biol 1993;121:1165-1172.
20. Bing DH, Almeda S, Isliker H, Lahav J, Hynes RO. Fibronectin binds to the C1q component of complement. Proc Natl Acad Sci USA 1982:79:4198-4201.
21. Azim AC, Marfatia SM, Korsgren C, Dotimas E, Cohen CM, Chishti AH. Human erythrocyte dematin and protein 4.2 (pallidin) are ATP binding proteins. Biochemistry 1996;35: 3001-3006.
22. Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA 2000;97:9082-9087.
23. Dai F, Yu L, He H, et al. Human serum and glucocorticoid-inducible kinase-like kinase (SGKL) phosphorylates glycogen syntheses kinase 3 beta (GSK-3beta) at serine-9 through direct interaction. Biochem Biophys Res Commun 2002;293:1191-1196.
24. Nakashima T, Sekiguchi T, Kuraoka A, et al. Molecular cloning of a human cDNA encoding a novel protein, DAD1, whose defect causes apoptotic cell death in hamster BHK21 cells. Mol Cell Biol 1993;13:6367-6374.
25. Martin-Gallardo A, McCombie WR, Gocayne JD, et al. Automated DNA sequencing and analysis of 106 kilobases from human chromosome 19q13.3. Nat Genet 1992;1:34-39.
26. Schaeffer HJ, Catling AD, Eblen ST, Collier LS, Krauss A, Weber MJ. MP1: A MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 1998;281:1668-1671.
27. Jankowski SA, De Jong P, Meltzer PS. Genomic structure of SAS, a member of the transmembrane 4 superfamily amplified in human sarcomas. Genomics 1995;25: 501-506.
28. Wilkie AOM, Patey SJ, Kan S, van den Ouweland AMW, Hamel BCJ. FGFs, their receptors, and human limb malformations: Clinical and molecular correlations. Am J Med Genet 2002;112:266-278.
29. Charng MJ, Zhang D, Kinnunen P, Schneider MD. A novel protein distinguishes between quiescent and activated forms of the type I transforming growth factor beta receptor. J Biol Chem 1998;273:9365-9368.
30. Rosenberg M, Fuchs E, Le Beau MM, Eddy RL, Shows TB. Three epidermal and one simple epithelial type II keratin genes map to human chromosome 12. Cytogenet Cell Genet 1991;57:33-38.
31. Chapin SJ, Bulinski JC. Non-neuronal 210 × 10(3) M(r) microtubule-associated protein (MAP4) contains a domain homologous to the microtubule-binding domains of neuronal MAP2 and tau. J Cell Sci 1991;98:27-36.
32. Wilton SD, Johnsen RD, Pedretti JR, Laing NG. Two distinct mutations in a single dystrophin gene: Identification of an altered splice-site as the primary Becker muscular dystrophy mutation. Am J Med Genet 1993;46:563-569.